# Long-Term Study of Nitisinone to Treat Alkaptonuria

> **NCT00107783** · PHASE2 · COMPLETED · sponsor: **National Human Genome Research Institute (NHGRI)** · enrollment: 40 (actual)

## Conditions studied

- Alkaptonuria

## Interventions

- **DRUG:** Nitisinone (NTBC)

## Key facts

- **NCT ID:** NCT00107783
- **Lead sponsor:** National Human Genome Research Institute (NHGRI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00107783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00107783, "Long-Term Study of Nitisinone to Treat Alkaptonuria". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00107783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*